Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Tremfya brand?

See the DrugPatentWatch profile for Tremfya

Tremfya is the brand name for guselkumab, a monoclonal antibody that inhibits interleukin-23 (IL-23). It's used to treat moderate-to-severe plaque psoriasis and psoriatic arthritis, and is developed by Janssen Biotech.



Other Questions About Tremfya :

is there a biosimilar for tremfya Does tremfya work better than taltz for psoriatic arthritis? Is tremfya safe for patients with latent tb? Tremfya used for? Is tremfya better than taltz for plaque psoriasis? How do new indications for tremfya affect patient eligibility? Can tremfya cause cancer?